Gustavo A. Rosario Benitez

Array ( [id] => 10063905 [patent_doc_number] => 09102736 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'Multispecific deimmunized CD3-binders' [patent_app_type] => utility [patent_app_number] => 13/323206 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 28 [patent_no_of_words] => 35120 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 359 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13323206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8393070 [patent_doc_number] => 20120230911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'TNF-ALPHA BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/314878 [patent_app_country] => US [patent_app_date] => 2011-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32257 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13314878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9191019 [patent_doc_number] => 20130330334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'ANTI CD4 ANTIBODIES TO PREVENT IN PARTICULAR GRAFT-VERSUS-HOST-DISEASE (GVHD)' [patent_app_type] => utility [patent_app_number] => 13/990996 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 27203 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228544 [patent_doc_number] => 20120142750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'INDOLEAMINE 2,3-DIOXYGENASE PATHWAYS IN THE GENERATION OF REGULATORY T CELLS' [patent_app_type] => utility [patent_app_number] => 13/308060 [patent_app_country] => US [patent_app_date] => 2011-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 25631 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13308060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043399 [patent_doc_number] => 20120071420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'MODIFIED T CELL RECEPTORS AND RELATED MATERIALS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/304841 [patent_app_country] => US [patent_app_date] => 2011-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17662 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071420.pdf [firstpage_image] =>[orig_patent_app_number] => 13304841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289266 [patent_doc_number] => 20120177596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/288299 [patent_app_country] => US [patent_app_date] => 2011-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17323 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13288299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227265 [patent_doc_number] => 20120141469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'CRIPTO ANTAGONISM OF ACTIVIN AND TGF-B SIGNALING' [patent_app_type] => utility [patent_app_number] => 13/276858 [patent_app_country] => US [patent_app_date] => 2011-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13724 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13276858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8127481 [patent_doc_number] => 20120088287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'CRIPTO ANTAGONISM OF ACTIVIN AND TGF-B SIGNALING' [patent_app_type] => utility [patent_app_number] => 13/276918 [patent_app_country] => US [patent_app_date] => 2011-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13723 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088287.pdf [firstpage_image] =>[orig_patent_app_number] => 13276918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465034 [patent_doc_number] => 20120270202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'Pre-Transplant Accommodated Organs Resistant To Anti-Donor Immunity' [patent_app_type] => utility [patent_app_number] => 13/274504 [patent_app_country] => US [patent_app_date] => 2011-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11493 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13274504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054101 [patent_doc_number] => 20120076791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Methods Of Treating Chronic Prostatitis/Chronic Pelvic Pain Syndrome' [patent_app_type] => utility [patent_app_number] => 13/248205 [patent_app_country] => US [patent_app_date] => 2011-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13929 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076791.pdf [firstpage_image] =>[orig_patent_app_number] => 13248205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9950931 [patent_doc_number] => 08999715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Use of common γ chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes' [patent_app_type] => utility [patent_app_number] => 13/240009 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 39 [patent_no_of_words] => 22771 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13240009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9094336 [patent_doc_number] => 20130273647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'Antigen-Specific T Cell Receptors and T Cell Epitopes' [patent_app_type] => utility [patent_app_number] => 13/823079 [patent_app_country] => US [patent_app_date] => 2011-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 41428 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13823079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10627610 [patent_doc_number] => 09345748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Anti-SSX-2 T cell receptors and related materials and methods of use' [patent_app_type] => utility [patent_app_number] => 13/820802 [patent_app_country] => US [patent_app_date] => 2011-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16306 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669493 [patent_doc_number] => 20110318762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Graft-Versus-Host Disease Predicting Marker and Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/204799 [patent_app_country] => US [patent_app_date] => 2011-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8410 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13204799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11679540 [patent_doc_number] => 09678061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-13 [patent_title] => 'Identification of T cell target antigens' [patent_app_type] => utility [patent_app_number] => 13/814263 [patent_app_country] => US [patent_app_date] => 2011-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25830 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10026104 [patent_doc_number] => 09067993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-30 [patent_title] => 'Antibody neutralizers of human granulocyte macrophage colony stimulating factor' [patent_app_type] => utility [patent_app_number] => 13/198558 [patent_app_country] => US [patent_app_date] => 2011-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 28335 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13198558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094119 [patent_doc_number] => 20120082663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'ANTI-CMET ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/193537 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 44102 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082663.pdf [firstpage_image] =>[orig_patent_app_number] => 13193537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094117 [patent_doc_number] => 20120082662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'ANTI-CMET ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/193532 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 44098 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082662.pdf [firstpage_image] =>[orig_patent_app_number] => 13193532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8617294 [patent_doc_number] => 20130022605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'ANTAGONISTS AGAINST TNFR1 AND METHODS OF USE THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/181834 [patent_app_country] => US [patent_app_date] => 2011-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 93 [patent_figures_cnt] => 93 [patent_no_of_words] => 75303 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13181834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094075 [patent_doc_number] => 20120082643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'Compositions and Methods for Modulating a Cytotoxic T Lymphocyte Immune Response' [patent_app_type] => utility [patent_app_number] => 13/180459 [patent_app_country] => US [patent_app_date] => 2011-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14539 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082643.pdf [firstpage_image] =>[orig_patent_app_number] => 13180459 [rel_patent_id] =>[rel_patent_doc_number] =>)